Liprotides kill cancer cells by disrupting the plasma membrane

Henriette S Frislev, Theresa Louise Boye, Jesper Nylandsted, Daniel Otzen

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

219 Downloads (Pure)


HAMLET (human α-lactalbumin made lethal to tumour cells) is a complex of α-lactalbumin (aLA) and oleic acid (OA) which kills transformed cells, while leaving fully differentiated cells largely unaffected. Other protein-lipid complexes show similar anti-cancer potential. We call such complexes liprotides. The cellular impact of liprotides, while intensely investigated, remains unresolved. To address this, we report on the cell-killing mechanisms of liprotides prepared by incubating aLA with OA for 1 h at 20 or 80 °C (lip20 and lip80, respectively). The liprotides showed similar cytotoxicity against MCF7 cells, though lip80 acts more slowly, possibly due to intermolecular disulphide bonds formed during preparation. Liprotides are known to increase the fluidity of a membrane and transfer OA to vesicles, prompting us to focus on the effect of liprotides on the cell membrane. Extracellular Ca(2+) influx is important for activation of the plasma membrane repair system, and we found that removal of Ca(2+) from the medium enhanced the liprotides' killing effect. Liprotide cytotoxicity was also increased by knockdown of Annexin A6 (ANXA6), a protein involved in plasma membrane repair. We conclude that MCF7 cells counteract liprotide-induced membrane permeabilization by activating their plasma membrane repair system, which is triggered by extracellular Ca(2+) and involves ANXA6.

Original languageEnglish
Article number15129
JournalScientific Reports
Publication statusPublished - 9 Nov 2017


  • Journal Article


Dive into the research topics of 'Liprotides kill cancer cells by disrupting the plasma membrane'. Together they form a unique fingerprint.

Cite this